The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of indole inhibitors of chemokine receptor 9 (CCR9).EBI
Cubist Pharmaceuticals
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design.EBI
Cubist Pharmaceuticals
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB.EBI
Cubist Pharmaceuticals
Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors.EBI
Cubist Pharmaceuticals
Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease.EBI
Cubist Pharmaceuticals
A series of heterocyclic inhibitors of phenylalanyl-tRNA synthetases with antibacterial activity.EBI
Cubist Pharmaceuticals
A series of spirocyclic analogues as potent inhibitors of bacterial phenylalanyl-tRNA synthetases.EBI
Cubist Pharmaceuticals
A series of quinoline analogues as potent inhibitors of C. albicans prolyl tRNA synthetase.EBI
Cubist Pharmaceuticals
Synthesis and structure-activity relationships of a series of novel thiazoles as inhibitors of aminoacyl-tRNA synthetases.EBI
Cubist Pharmaceuticals
Structure-based discovery of LpxC inhibitors.EBI
Cubist Pharmaceuticals
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors.EBI
Cubist Pharmaceuticals